PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A 30-day randomized double-blind trial indicated the efficacy of a topical formulation of D. ammoniacum gum extract in treating melasma [PMID:33964194]
In a rat model, topical application of 5%, 10%, and 20% gum extract ointments significantly decreased wound areas compared to controls [PMID:36240871]
Aqueous gum solution showed significant anticonvulsant activity in PTZ-induced mice models [PMID:28255314] and anti-epileptogenic effects in rats [PMID:32851611], although another cellular model suggested it might increase neuronal excitability [PMID:29881430]
Essential oil (50-100 mg/kg) improved memory impairment induced by D-galactose and scopolamine in mice [PMID:33680015]; seed extracts also showed nootropic effects in mice [PMID:33669503]
Essential oil and aqueous extracts reduced viability of A549 cancer cells [PMID:35983460]; gum extracts affected HT-29 colon cancer cells [PMID:37724146]; and Sal-Ammoniac extract inhibited Lewis lung cancer cell proliferation in vitro and in vivo [PMID:18619270]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34848241 (2022) — Purification, structural characterization and antioxidant activity of a new arabinogalactan from Dorema ammoniacum gum. · International journal of biological macromolecules
- 2.PMID: 36240871 (2022) — Determination of the effectiveness of Dorema ammoniacum gum on wound healing: an experimental study. · Journal of wound care
- 3.PMID: 35156874 (2023) — Composition of the essential oil of different plant organs in Dorema ammoniacum D. Don and Dorema aucheri Boiss. accessions collected from Iran. · Natural product research
- 4.PMID: 28255314 (2017) — Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors. · Research in pharmaceutical sciences
- 5.PMID: 29881430